CatherineFWelshMD

Oncology • Miami, FL

Physician

Join to view full profile

Dr. Welsh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Welsh's full profile

Already have an account?

Office
1475 NW 12th Ave
Miami, FL 33136
Phone+1 305-243-6604

Fax+1 305-243-4905

Education & Training

University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1994 - 1997
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1988
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1984 - 1987
Virginia Commonwealth University School of MedicineClass of 1984

Certifications & Licensure

FL State Medical License 1995 - 2025
OH State Medical License 1988 - 1998
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Top Doctors:South Florida Castle Connolly, 2012

Clinical Trials

A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Start of enrollment: 2008 Oct 21
Completed
Phase 1, Phase 2

Publications & Presentations

PubMed

79 citations
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical...
Alberto J. Montero, Claudia Marcela Diaz-Montero, Y. E. Deutsch, Judith Hurley, Leonidas G. Koniaris
Breast Cancer Research and Treatment. 2012-02-01
59 citations
Final results of a phase II study of nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
C. Lobo, Gilberto Lopes, Odalys Baez, Aurelio Castrellon, Annapoorna Ferrell
Breast Cancer Research and Treatment. 2010-06-29
10 citations
A Phase II trial of split, low-dose docetaxel and low-dose capecitabine: a tolerable and efficacious regimen in the first-line treatment of patients with HER2/neu-nega...
Orlando Silva, Gilberto Lopes, Daniel Morgenzstern, C. Lobo, Philomena Doliny
Clinical Breast Cancer. 2008-04-01

Press Mentions

Woman to WomanMay 13th, 2021

Grant Support

RHO Gtpase And Cell Cycle Regulation In Breast CancerNational Cancer Institute2001–2005